CJC-1295 no DAC half-life is about 30 minutes, far shorter than the DAC version's 6-8 days. Compare dosing, timing, and research use in the US.
CJC-1295 no DAC has a half-life of roughly 30 minutes in the bloodstream. That short window is the main practical difference between it and CJC-1295 with DAC, which stays active for about 6 to 8 days. CJC-1295 no DAC is also called Mod GRF 1-29, and both names describe the same 29-amino-acid growth hormone-releasing hormone analog.
The half-life number drives everything else: how often the peptide is injected, how closely it mimics natural growth hormone pulses, and why it is usually stacked with a second secretagogue.
Why CJC-1295 No DAC Breaks Down So Fast
DAC stands for Drug Affinity Complex. Attach DAC to CJC-1295 and the molecule binds to serum albumin, which acts like a slow-release carrier and keeps the peptide circulating for days. Remove it and that carrier disappears.
Without albumin binding, the peptide is exposed to dipeptidyl peptidase IV (DPP-IV) and other plasma enzymes. They cleave it quickly. The measured half-life lands at approximately 30 minutes, with some assays reporting 20 to 30 minutes depending on the model used.
This is why searches around cjc 1295 no dac half-life almost always lead to the same follow-up question: how do you time the injection? A 30-minute half-life means the compound creates a brief spike, not a steady level.
CJC-1295 No DAC vs CJC-1295 DAC
The cjc-1295 dac half life is roughly 200 to 400 times longer than the no-DAC form. That single chemical difference changes injection frequency, growth hormone pulse shape, and the way the two peptides are studied.
| Feature | CJC-1295 No DAC (Mod GRF 1-29) | CJC-1295 With DAC |
|---|---|---|
| Half-life | About 30 minutes | About 6 to 8 days |
| Albumin binding | None | Yes, via DAC |
| Typical injection frequency in research | 1 to 3 times daily | 1 to 2 times weekly |
| Growth hormone pattern | Short, pulsatile spike | Continuous elevation |
| Common stacking partner | Ipamorelin, GHRP-2, GHRP-6 | Rarely stacked |
The cjc-1295 dac vs no dac comparison is less about potency and more about signal shape. Some research models want a sharp pulse that mimics the body's own rhythm; others want a baseline level that lasts for days.
Neither form is approved by the FDA for human use, and neither has a finished prescription product in the United States.
What a 30-Minute Half-Life Means for Timing
A half-life of 30 minutes means plasma levels peak within about 15 to 30 minutes and fall sharply after that. Most of the peptide is cleared within two to three hours.
- Injections are usually timed before sleep or after resistance training, when natural growth hormone release is already climbing.
- A single daily dose will not keep the peptide elevated around the clock.
- Researchers who want sustained exposure generally choose the DAC version instead.
By contrast, the DAC form can keep growth hormone signaling elevated for a week or more from one injection. Sustained elevation is not automatically better; it can blunt the body's own pulsatile release and has been linked in some reports to joint pain, swelling, and insulin resistance.
CJC-1295 No DAC Dosage and Stacking
There is no FDA-approved cjc-1295 no dac dosage. Published human data is scarce, and most protocols discussed online begin around 100 mcg per injection, one to three times per day.
Because the half-life is so short, the peptide is almost always paired with a growth hormone secretagogue that has a similar clearance profile. Ipamorelin is the most common choice, followed by GHRP-2 and GHRP-6. People comparing notes in cjc 1295 no dac ipamorelin reddit threads often report combining both peptides in one syringe to amplify a single pulse.
Stacking does not make the peptide safer or legal. It simply changes the size and shape of the growth hormone signal in a research setting.
Safety and Legal Status in the US
CJC-1295 is not FDA-approved for human use in the United States. It is sold as a research chemical, which means purity, sterility, and actual peptide content are not verified by any regulator.
Reported side effects include injection-site irritation, flushing, headache, and temporary water retention. Because the no-DAC form produces pulses rather than continuous elevation, some researchers argue it carries a lower risk of the joint pain and blood sugar changes associated with sustained growth hormone exposure. That argument is theoretical, not proven.
Anyone considering these compounds should consult a licensed healthcare professional. Peptides sold online are not a substitute for medical treatment, and self-dosing carries real risk.
Key Conclusions About CJC-1295 No DAC Half-Life
- CJC-1295 no DAC has a half-life of approximately 30 minutes.
- CJC-1295 with DAC has a half-life of about 6 to 8 days because DAC binds the peptide to albumin.
- Mod GRF 1-29 and CJC-1295 no DAC are the same peptide.
- The short half-life requires frequent injections but produces a growth hormone pulse that more closely resembles natural release.
- CJC-1295 is not FDA-approved for human use in the United States.
Frequently Asked Questions
How long does CJC-1295 no DAC stay in your system?
The peptide's half-life is about 30 minutes, and most of it is cleared from the bloodstream within two to three hours. Sensitive lab assays may still detect fragments slightly longer, but the active window is short. This is why it is typically injected multiple times per day in research settings.
Is CJC-1295 no DAC the same as Mod GRF 1-29?
Yes. CJC-1295 no DAC and Mod GRF 1-29 refer to the same tetrasubstituted 29-amino-acid peptide. The "no DAC" label simply clarifies that the Drug Affinity Complex, which extends half-life by binding to albumin, has been removed. Some vendors list it under both names.
Which lasts longer, CJC-1295 with DAC or without DAC?
CJC-1295 with DAC lasts far longer, with a half-life of about 6 to 8 days because DAC binds the peptide to albumin in the blood. The no-DAC version lasts roughly 30 minutes. That difference means the DAC form is dosed weekly while the no-DAC form is dosed one to three times daily.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.